Listed

Pharming Group N.V.

PHARNasdaqCIK 1828316HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$145.3m, FY2025
Shareholders' equity$277.1m, FY2025
Line itemUnitperiod not labelled2018-12-31period not labelled2019-12-31period not labelled2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m91.9Cash and equivalents, period not labelled, at 2018-12-31$91.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure74.3Cash and equivalents, period not labelled, at 2019-12-31$74.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-04-05, accession 0001628280-23-010793.Report this figure205Cash and equivalents, period not labelled, at 2020-12-31$205.2m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-04-04, accession 0001828316-24-000008.Report this figure192Cash and equivalents, FY2021, at 2021-12-31$191.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-03, accession 0001828316-25-000017.Report this figure207Cash and equivalents, FY2022, at 2022-12-31$207.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure61.7Cash and equivalents, FY2023, at 2023-12-31$61.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure54.9Cash and equivalents, FY2024, at 2024-12-31$54.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure145Cash and equivalents, FY2025, at 2025-12-31$145.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure
Current assets$mnot reported119Current assets, period not labelled, at 2019-12-31$119.4m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure263Current assets, period not labelled, at 2020-12-31$263.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure249Current assets, FY2021, at 2021-12-31$249.4m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-04-05, accession 0001628280-23-010793.Report this figure278Current assets, FY2022, at 2022-12-31$277.5m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-04-04, accession 0001828316-24-000008.Report this figure316Current assets, FY2023, at 2023-12-31$316.3m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-04-03, accession 0001828316-25-000017.Report this figure278Current assets, FY2024, at 2024-12-31$278.4m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure299Current assets, FY2025, at 2025-12-31$299.5m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure
Total assets$mnot reported256Total assets, period not labelled, at 2019-12-31$255.9m. XBRL concept ifrs-full:Assets. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure418Total assets, period not labelled, at 2020-12-31$418.5m. XBRL concept ifrs-full:Assets. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure397Total assets, FY2021, at 2021-12-31$397.3m. XBRL concept ifrs-full:Assets. 20-F filed 2023-04-05, accession 0001628280-23-010793.Report this figure426Total assets, FY2022, at 2022-12-31$425.8m. XBRL concept ifrs-full:Assets. 20-F filed 2024-04-04, accession 0001828316-24-000008.Report this figure463Total assets, FY2023, at 2023-12-31$462.9m. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-03, accession 0001828316-25-000017.Report this figure400Total assets, FY2024, at 2024-12-31$400.0m. XBRL concept ifrs-full:Assets. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure500Total assets, FY2025, at 2025-12-31$500.0m. XBRL concept ifrs-full:Assets. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure
Current liabilities$mnot reported114Current liabilities, period not labelled, at 2019-12-31$114.3m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure76.8Current liabilities, period not labelled, at 2020-12-31$76.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure46.8Current liabilities, FY2021, at 2021-12-31$46.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2023-04-05, accession 0001628280-23-010793.Report this figure59.7Current liabilities, FY2022, at 2022-12-31$59.7m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-04-04, accession 0001828316-24-000008.Report this figure78.0Current liabilities, FY2023, at 2023-12-31$78.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-04-03, accession 0001828316-25-000017.Report this figure73.8Current liabilities, FY2024, at 2024-12-31$73.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure116Current liabilities, FY2025, at 2025-12-31$115.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure
Shareholders' equity$m64.1Shareholders' equity, period not labelled, at 2018-12-31$64.1m. XBRL concept ifrs-full:Equity. 20-F filed 2022-04-06, accession 0001628280-22-008574.Report this figure117Shareholders' equity, period not labelled, at 2019-12-31$117.4m. XBRL concept ifrs-full:Equity. 20-F filed 2023-04-05, accession 0001628280-23-010793.Report this figure183Shareholders' equity, period not labelled, at 2020-12-31$183.4m. XBRL concept ifrs-full:Equity. 20-F filed 2024-04-04, accession 0001828316-24-000008.Report this figure193Shareholders' equity, FY2021, at 2021-12-31$192.9m. XBRL concept ifrs-full:Equity. 20-F filed 2025-04-03, accession 0001828316-25-000017.Report this figure205Shareholders' equity, FY2022, at 2022-12-31$204.6m. XBRL concept ifrs-full:Equity. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure219Shareholders' equity, FY2023, at 2023-12-31$218.8m. XBRL concept ifrs-full:Equity. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure221Shareholders' equity, FY2024, at 2024-12-31$221.1m. XBRL concept ifrs-full:Equity. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure277Shareholders' equity, FY2025, at 2025-12-31$277.1m. XBRL concept ifrs-full:Equity. 20-F filed 2026-04-02, accession 0001828316-26-000015.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.